Reuters logo
BRIEF-Eagle Pharmaceuticals posts Q2 adj. earnings $0.49/shr
2017年8月9日 / 上午11点04分 / 3 个月前

BRIEF-Eagle Pharmaceuticals posts Q2 adj. earnings $0.49/shr

Aug 9 (Reuters) - Eagle Pharmaceuticals Inc

* Eagle Pharmaceuticals Inc reports second quarter 2017 results

* Q2 earnings per share $0.28

* Q2 adjusted non-GAAP earnings per share $0.49

* Q2 revenue $50.1 million versus I/B/E/S view $52.5 million

* Q2 earnings per share view $0.51 -- Thomson Reuters I/B/E/S

* Eagle Pharmaceuticals Inc - board of directors approved an additional share buyback program of $100 million

* Eagle Pharmaceuticals Inc - ‍2017 SG&A and research and development guidance remains unchanged​

* Eagle Pharmaceuticals Inc - ‍company enters into $150 million amended and restated credit agreement​

* Eagle Pharmaceuticals Inc - ‍implements initial expense reduction program​

* Eagle Pharmaceuticals Inc - ‍have identified $10 million in expense reductions on an annualized basis which will begin impacting company’s P&L in 2018​ Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below